Zum Inhalt springen
Global sound
The Bio Report

The Bio Report

Targeting Cancer Survival Genes in Solid Tumors

· 46 Min. · Folge 174

Shownotes

Most cancer therapies hit one or a few pathways that tumors can escape by mutating, activating alternative survival routes, or pumping drugs out, leading to relapse and poor survival in indications such as liver, ovarian, and prostate cancer. Nuago is developing single-construct short RNAs that simultaneously silence many survival genes in cancer cells to achieve durable tumor cell killing with minimal toxicity to normal tissue. Nuago CEO Robert Schickel discusses the biology behind toxic RNA seeds and tumor-suppressive microRNAs; the company’s lead programs in liver, ovarian, and prostate cancer; and the implications if its cancer-agnostic RNA platform can live up to its preclinical promise.

Website: thebioreport.podbean.com

Live, letzte Stunde: 9.831 Songs auf 5.236 Sendern in 145 Ländern

Entdecke die Welt über das Radio

Mehr zum Entdecken (7)

Etwas Schönes gehört? Speicher es oder öffne es direkt in Spotify.

★ Künstler der Woche Der schnellste Aufsteiger im Radio diese Woche
Dein Song hier? Ab € 9 pro Woche →
RADIO VICTORIA EN CRISTOWeiterhören